Cardiovascular disease (CVD) remains the leading cause of mortality among women in the United States, claiming the lives of over 400,000 women annually. This stark reality underscores the urgent imperative to delineate risk factors that disproportionately impact women. Among these risk factors, chronic stress and stress-related psychiatric conditions such as anxiety, depression, and post-traumatic stress disorder (PTSD) have drawn increasing attention for their profound effects on cardiovascular health. Women experience these disorders at higher rates compared to men, yet the mechanisms linking mental health and cardiovascular risk in women remain incompletely understood.

The widespread use of hormonal contraceptives—by approximately 9.1 million women in the U.S.—adds another layer of complexity. These contraceptives function by modulating endogenous hormone levels, suppressing natural estradiol and progesterone production, but their broader systemic effects, particularly in the context of psychological stress, have remained underexplored. Historically, research on hormonal contraception has largely excluded women with significant psychiatric comorbidities, focusing instead on young, generally healthy populations, thus limiting clinical guidance for women managing both hormone use and mental health challenges.

Bridging this critical knowledge gap, Dr. Jordan Thomas and colleagues undertook an expansive analysis utilizing healthcare records from 31,824 women enrolled in the Mass General Brigham Biobank, a rich repository of longitudinal health data. By cross-referencing diagnostic codes for stress-related disorders, major adverse cardiovascular events (MACE), deep-vein thrombosis, and prescriptions for hormonal contraceptives, the team delineated patterns of cardiovascular risk stratified by mental health status and hormone use.

Their findings reveal a striking dichotomy: in women with anxiety or depression, hormonal contraceptive use was correlated with a reduced risk of major adverse cardiovascular events. This counterintuitive protective association contrasts with the prevailing assumption that hormonal manipulation might exacerbate cardiovascular risk. However, this protective effect was absent in women diagnosed with PTSD, suggesting a potentially differential pathophysiological response linked to this severe stress disorder. These preliminary results raise provocative questions about the mechanisms by which psychological stress modulates hormonal effects on cardiovascular function.

The absence of a protective effect in women with PTSD implicates complex neuroendocrine and immunological pathways, given PTSD’s association with heightened sympathetic nervous system activity, chronic inflammation, and endothelial dysfunction—all contributory factors to cardiovascular pathology. Hormonal contraceptives, by altering estrogen and progesterone levels, may interact with these stress-induced physiological disturbances, modulating cardiovascular risk in ways that warrant further clarification.

Implications for clinical practice are profound. The findings suggest that assessment of psychiatric history, particularly PTSD, could become integral to contraceptive counseling and cardiovascular risk stratification in women. If substantiated through future research, this evidence could guide personalized medicine approaches, optimizing contraceptive choice in the context of mental health to mitigate avoidable cardiovascular events.

Looking forward, Dr. Seligowski’s team envisions a clinical study designed to collect prospective physiological data on the impact of specific hormonal contraceptive formulations on cardiovascular risk markers, including blood pressure regulation, vascular endothelial function, and biomarkers of coagulation—a key determinant of thrombotic risk. This longitudinal study aims to dissect how these parameters differ among women with and without stress-related psychiatric disorders, with participants undergoing annual follow-ups to monitor emergent clinical events such as thrombotic episodes.

Such research endeavors have the potential to unravel the biological substrates driving the observed epidemiological trends and to translate these insights into actionable clinical strategies. By integrating psychiatric evaluation with cardiovascular risk assessment and hormonal management, healthcare providers may in the future avert a significant fraction of female cardiovascular morbidity and mortality currently unaddressed by conventional paradigms.

This pioneering investigation represents a pivotal advancement in the domain of sex-specific medicine, emphasizing the imperative to consider psychological stressors as modulators of cardiovascular risk, particularly in the context of pharmaceutical hormone exposure. As the field moves towards precision medicine, understanding the interdependence of mental health and endocrine influences on cardiac outcomes will be critical to enhancing healthspan and quality of life for women.

Authorship of this study included key contributors from Mass General Brigham—Robyn Ellis, Shady Abohashem, Anahita Dua, Emily Lau, Karen Miller, Rachel Rosovsky, Ahmed Tawakol, and Michael Osborne—reflecting a multidisciplinary collaboration harnessing expertise across psychiatry, cardiovascular medicine, and epidemiology. Disclosure statements note industry relationships for some authors, emphasizing transparency in potential conflicts of interest.

Published in the prestigious journal JAMA Network Open, this research stands as a significant call to action for both the scientific community and clinicians alike. Its findings illuminate the intricate connections between psychiatric health, hormonal regulation, and cardiovascular disease, charting a promising course for future inquiry and intervention strategies aimed at reducing the disproportionate burden of cardiovascular disease among women.

Subject of Research: The investigation focused on the intersection of hormonal contraceptive use, stress-related psychiatric disorders, and their combined influence on cardiovascular and thrombotic risk in women.

Article Title: Hormonal contraceptive use, stress disorders, and cardiovascular and thrombotic risk in women

News Publication Date: 2-Jan-2026

Web References:
DOI link: http://dx.doi.org/10.1001/jamanetworkopen.2025.51878

Keywords: Clinical medicine, cardiovascular disease, hormonal contraception, stress disorders, PTSD, anxiety, depression, thrombosis, women’s health, neurocardiology, precision medicine

A groundbreaking study conducted by researchers at Rice University, and recently published in the journal Hormones and Behavior, delves deeply into the neuropsychological consequences of hormonal contraceptive use. This experimental research explores a nuanced question that has long intrigued both clinicians and users alike: how does hormonal birth control affect the way women process and remember emotional experiences? The findings reveal that hormonal contraceptives may modulate not only real-time emotional responses but also the subsequent encoding and recall of emotional memories, which in turn could have significant implications for mental health.

Building on the hypothesis that reproductive hormones influence brain regions integral to emotion and memory, the researchers designed a controlled experimental setup comparing women using hormonal contraceptives with those experiencing natural menstrual cycles. Participants were exposed to a range of affectively charged visual stimuli, including positively, negatively, and neutrally valenced images, while being guided to employ various emotion regulation strategies. These strategies, encompassing distancing, reinterpretation, and immersion, reflect common cognitive approaches individuals use to manage their emotional reactions.

Intriguingly, the study found that women on hormonal contraceptives exhibited heightened emotional reactivity compared to those who were naturally cycling, displaying more intense responses to emotionally charged stimuli. When employing cognitive distancing or reinterpretation—the techniques aimed at downregulating negative affect—these women demonstrated a reduced ability to recall fine-grained details of negative events. However, their memory for the general occurrence of such events remained unaffected. This selective attenuation of unpleasant memory details suggests a potential protective mechanism, buffering against the persistent rumination that often exacerbates mood disorders.

In contrast, both groups, regardless of contraceptive status, showed improved memory retention for positive images when using immersion strategies, which involve engaging deeply with the emotional content. This enhancement in the recall of positive experiences aligns with the broader psychological literature suggesting that emotional salience can enhance mnemonic encoding. The differential pattern uncovered by this study highlights a complexity in how hormonal contraceptives might shape the interplay between emotion regulation, memory, and mental health resilience.

The neurological substrates likely underpinning these observations involve brain networks responsible for integrating emotional valuation and memory consolidation, including the amygdala, hippocampus, and prefrontal cortex. Hormonal contraceptives, through synthetic estrogen and progestin, appear to influence neurotransmission and receptor sensitivity within these regions, thereby altering cognitive-emotional processing. Such modulation may change synaptic plasticity dynamics, ultimately affecting how emotional stimuli are encoded and retrieved.

Importantly, these findings carry broader implications regarding the mental health trajectories of women using hormonal birth control. Given that emotion regulation strategies and memory processes are deeply intertwined with conditions such as depression and anxiety, this research provides a window into how synthetic hormones might subtly recalibrate these mechanisms. The decreased retrieval of negative details after cognitive regulation could help mitigate negative affective states, offering a possible explanation for anecdotal reports of mood stabilization among some contraceptive users.

Beatriz Brandao, lead author of the study and a graduate student in the Department of Psychological Sciences at Rice University, emphasized the novelty of these findings. She remarked that hormonal contraceptives do more than prevent pregnancy—they influence the cerebral circuits that govern emotional experience and recollection. This revelation challenges the traditional view of birth control as merely a reproductive health tool and points towards a more integrated understanding of how these medications impact psychological wellness.

The co-authors, including Bryan Denny and Stephanie Leal, both prominent figures in psychological neuroscience, underscore the importance of ongoing research in this field. Their intention is to broaden investigations to examine natural menstrual cycle phases and to differentiate the effects of diverse contraceptive modalities, such as oral pills versus intrauterine devices. Such work aims to parse out how synthetic hormones compare to endogenous hormonal fluctuations in shaping emotional-cognitive outcomes.

This research also prompts crucial questions for clinical practice and personal decision-making. If hormonal contraceptives modulate memory of emotional events, particularly reducing recall of adverse details, this could influence the lived experiences of users in profound ways. It raises the possibility that contraceptive choice might be tailored not only to physical health needs but also to cognitive-emotional profiles and mental health considerations, ultimately fostering more personalized reproductive healthcare.

Underlying the mechanism is the fundamental principle of emotion regulation—the ways individuals attempt to influence their own affective states. Cognitive strategies like distancing and reinterpretation typically act by altering attention and appraisal processes, thereby diminishing emotional intensity. The finding that hormonal contraceptives amplify the effect of these strategies on memory suppression of negative specifics adds a novel dimension, suggesting an interaction between pharmacological and cognitive factors.

This study offers fresh insight into a complex biopsychological phenomenon, with critical relevance at a time when millions rely daily on hormonal contraception. It advances our understanding of how synthetic reproductive hormones extend their influence into the domain of mental health, guiding future investigations into the nuanced balance between beneficial and potentially adverse neuropsychological effects. Ultimately, this knowledge equips women and healthcare providers with better information to navigate choices balancing reproductive autonomy and emotional well-being.

As Brandao and her team continue to explore these intricate relationships, their research heralds a new era of interdisciplinary study uniting endocrinology, psychology, and neuroscience. The integration of emotion regulation processes with hormonal status represents a vital step forward in deciphering the substrates of women’s mental health and underscores the necessity of inclusive research paradigms that account for the complexities of hormonal contraceptive effects.

Subject of Research: People

Article Title: Emotion regulation strategies differentially impact memory in hormonal contraceptive users

News Publication Date: 25-Aug-2025

Web References:
https://www.sciencedirect.com/science/article/pii/S0018506X2500131X
http://dx.doi.org/10.1016/j.yhbeh.2025.105805

References: Hormones and Behavior, 2025.

Keywords: Birth control, Human reproduction, Behavioral psychology